Institutes to Operate in Countries Around the World; First Centers to Open
in Japan, U.S., France and China Kenneth P. Moritsugu, M.D., Former Acting Surgeon General, Appointed to
Lead Global Effort
NEW BRUNSWICK, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced the establishment of the Johnson & Johnson Diabetes Institute (JJDI) to transform diabetes care by providing comprehensive training on the latest practice standards, new diabetes tools and technologies and reimbursement solutions to physicians, nurses, physician assistants and diabetes educators around the globe. Former Acting U.S. Surgeon General and public health expert, Kenneth P. Moritsugu, M.D., M.P.H., will serve as the Institute's chairman.
The Institute is part of a new effort to address the growing epidemic of diabetes, which now affects more than 180 million people worldwide and is predicted to double to 360 million people by 2030. Toward this end, Johnson & Johnson affiliates will invest the necessary resources to open and operate new state-of-the-art instructional facilities worldwide, starting with Japan in 2007 and the U.S., China and France by mid-2008.
"In sheer numbers and the costs in human suffering and money spent on
health care, diabetes has reached crisis proportions around the globe,"
said Dr. Moritsugu, who has type I diabetes and is an advocate for improved
diabetes care. "At a time when the annual direct health care costs for
diabetes worldwide are estimated to be at least $232 billion, new
strategies are needed to raise the level of care for people with diabetes,
including stepped-up education and hands-on training of health
p
'/>"/>
| SOURCE Johnson & Johnson Copyright©2007 PR Newswire. All rights reserved |